Evidence map›Paper›PMID 30424781›Full record

ArticleParasites & vectors2018

Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.

Clarer Jones, Billy Ngasala, Yahya A Derua, Donath Tarimo, Lisa Reimer, Moses Bockarie, Mwelecele N Malecela

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Evaluating the Diagnostic Test Accuracy of Molecular Xenomonitoring Methods for Characterizing Community Burden of Lymphatic Filariasis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Pooled it
  4. Pooled it
  5. Article
  6. Prevalence ofIJID regions · 2024
    Article
  7. Prevalence of elephantiasis, an overlooked disease in Southern Africa: a comprehensive review.The journal of venomous animals and toxins including tropical diseases · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Assessing the Presence ofTropical medicine and infectious disease · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Clarer JonesDepartment of Parasitology and Medical Entomology, Muhimbili University of Health and Allied Sciences, P. O. Box 65011, Dar es Salaam, Tanzania. clarajones2003@yahoo.co.uk.
Billy NgasalaDepartment of Parasitology and Medical Entomology, Muhimbili University of Health and Allied Sciences, P. O. Box 65011, Dar es Salaam, Tanzania.
Yahya A DeruaNational Institute for Medical Research, P. O. Box 9653, Dar es Salaam, Tanzania.
Donath TarimoDepartment of Parasitology and Medical Entomology, Muhimbili University of Health and Allied Sciences, P. O. Box 65011, Dar es Salaam, Tanzania.
Lisa ReimerLiverpool School of Tropical Medicine, Liverpool, UK.
Moses BockarieEuropean and Development Countries Clinical Trials Partnership, Cape Town, South Africa.
Mwelecele N MalecelaWHO Regional Office for Africa, Brazzaville, Republic of the Congo.
Muhimbili University of Health and Allied Sciences · TZLiverpool School of Tropical Medicine · GBNational Institute for Medical Research · TZWorld Health Organization Regional Office for Africa · CG

Funding

TDR/WHO HQTDR1409931World Health Organization 001
6 · The paper itself

Abstract

backgroundControl of lymphatic filariasis (LF) in most of the sub-Saharan African countries is based on annual mass drug administration (MDA) using a combination of ivermectin and albendazole. Monitoring the impact of this intervention is crucial for measuring the success of the LF elimination programmes. This study assessed the status of LF infection in Rufiji district, southeastern Tanzania after twelve rounds of MDA.

methodsCommunity members aged between 10 and 79 years were examined for Wuchereria bancrofti circulating filarial antigens (CFA) using immunochromatographic test cards (ICTs) and antigen-positive individuals were screened for microfilaraemia. All study participants were examined for clinical manifestation of LF and interviewed for drug uptake during MDA rounds. Filarial mosquito vectors were collected indoor and outdoor and examined for infection with W. bancrofti using a microscope and quantitative real-time polymerase chain reaction (qPCR) techniques.

resultsOut of 854 participants tested, nine (1.1%) were positive for CFA and one (0.1%) was found to be microfilaraemic. The prevalence of hydrocele and elephantiasis was 4.8% and 2.9%, respectively. Surveyed drug uptake rates were high, with 70.5% of the respondents reporting having swallowed the drugs in the 2014 MDA round (about seven months before this study). Further, 82.7% of the respondents reported having swallowed the drugs at least once since the inception of MDA programme in 2000. Of the 1054 filarial vectors caught indoors and dissected to detect W. bancrofti infection none was found to be infected. Moreover, analysis by qPCR of 1092 pools of gravid Culex quinquefasciatus collected outdoors resulted in an estimated infection rate of 0.1%. None of the filarial vectors tested with qPCR were found to be infective.

conclusionAnalysis of indices of LF infection in the human population and filarial mosquito vectors indicated a substantial decline in the prevalence of LF and other transmission indices, suggesting that local transmission was extremely low if occurring at all in the study areas. We, therefore, recommend a formal transmission assessment survey (TAS) to be conducted in the study areas to make an informed decision on whether Rufiji District satisfied WHO criteria for stopping MDA.

Indexed as

AdolescentAdultAgedAlbendazoleAnimalsAntiprotozoal AgentsChildCulexElephantiasis, FilarialFemaleFilaricidesHumansIvermectinMaleMass Drug AdministrationMiddle AgedAlbendazoleAntiprotozoal AgentsFilaricidesIvermectinCirculating filarial antigensElephantiasisHydroceleLymphatic filariasisMass drug administrationMicrofilaremiaTanzaniaWuchereria bancrofti

Identifiers

PMID30424781
PMCPMC6234578
OpenAlexW2901321851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.